| Azacitidine and venetoclax in previously untreated acute myeloid leukemia CD DiNardo, BA Jonas, V Pullarkat, MJ Thirman, JS Garcia, AH Wei, ... New England Journal of Medicine 383 (7), 617-629, 2020 | 1774 | 2020 |
| Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA … MA Sanz, FL Coco, G Martın, G Avvisati, C Rayón, T Barbui, ... Blood, The Journal of the American Society of Hematology 96 (4), 1247-1253, 2000 | 810 | 2000 |
| Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of … X Bosch, M Rovira, M Sitges, A Domènech, JT Ortiz-Pérez, TM de Caralt, ... Journal of the American College of Cardiology 61 (23), 2355-2362, 2013 | 695 | 2013 |
| A Modified AIDA Protocol With Anthracycline-Based Consolidation Results in High Antileukemic Efficacy and Reduced Toxicity in Newly Diagnosed PML/RAR-Positive Acute … MA Sanz, G Martı́n, C Rayón, J Esteve, M González, J Dı́az-Mediavilla, ... Blood, The Journal of the American Society of Hematology 94 (9), 3015-3021, 1999 | 540 | 1999 |
| Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older … M Aoudjhane, M Labopin, NC Gorin, A Shimoni, T Ruutu, HJ Kolb, ... Leukemia 19 (12), 2304-2312, 2005 | 517 | 2005 |
| Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin J De La Serna, P Montesinos, E Vellenga, C Rayón, R Parody, A León, ... Blood, The Journal of the American Society of Hematology 111 (7), 3395-3402, 2008 | 424 | 2008 |
| Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome … P Montesinos, JM Bergua, E Vellenga, C Rayón, R Parody, J De La Serna, ... Blood, The Journal of the American Society of Hematology 113 (4), 775-783, 2009 | 381 | 2009 |
| Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a … S Brunet, M Labopin, J Esteve, J Cornelissen, G Socié, AP Iori, ... Journal of clinical oncology 30 (7), 735-741, 2012 | 359 | 2012 |
| Documento de consenso de la Sociedad Española de Reumatología sobre la fibromialgia J Rivera, C Alegre, FJ Ballina, J Carbonell, L Carmona, B Castel, ... Reumatología clínica 2, S55-S66, 2006 | 322 | 2006 |
| Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post … M Pratcorona, S Brunet, J Nomdedéu, JM Ribera, M Tormo, R Duarte, ... Blood, The Journal of the American Society of Hematology 121 (14), 2734-2738, 2013 | 310 | 2013 |
| Treatment of high-risk Philadelphia chromosome–negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual … JM Ribera, A Oriol, M Morgades, P Montesinos, J Sarrà, ... Journal of Clinical Oncology 32 (15), 1595-1604, 2014 | 293 | 2014 |
| Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from … M Mohty, M Labopin, L Volin, A Gratwohl, G Socié, J Esteve, R Tabrizi, ... Blood, The Journal of the American Society of Hematology 116 (22), 4439-4443, 2010 | 278 | 2010 |
| Therapy-related acute promyelocytic leukemia M Beaumont, M Sanz, PM Carli, F Maloisel, X Thomas, L Detourmignies, ... Journal of Clinical Oncology 21 (11), 2123-2137, 2003 | 266 | 2003 |
| Complement-mediated cell death induced by rituximab in B-cell lymphoproliferative disorders is mediated in vitro by a caspase-independent mechanism involving the generation of … B Bellosillo, N Villamor, A López-Guillermo, S Marcé, J Esteve, E Campo, ... Blood, The Journal of the American Society of Hematology 98 (9), 2771-2777, 2001 | 266 | 2001 |
| Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia F Bosch, A Ferrer, A López‐Guillermo, E Giné, B Bellosillo, N Villamor, ... British journal of haematology 119 (4), 976-984, 2002 | 245 | 2002 |
| Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia … JM Ribera, A Oriol, M González, B Vidriales, S Brunet, J Esteve, ... haematologica 95 (1), 87, 2010 | 241 | 2010 |
| Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT P Tsirigotis, M Byrne, C Schmid, F Baron, F Ciceri, J Esteve, NC Gorin, ... Bone marrow transplantation 51 (11), 1431-1438, 2016 | 221 | 2016 |
| Identification of ‘short‐lived’and ‘long‐lived’patients at presentation of idiopathic myelofibrosis F Cervantes, A Pereira, J Esteve, M Rafel, F Cobo, C Rozman, ... British journal of haematology 97 (3), 635-640, 1997 | 215 | 1997 |
| Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (“accelerated” chronic lymphocytic leukemia) with aggressive … E Giné, A Martinez, N Villamor, A López-Guillermo, M Camos, D Martinez, ... Haematologica 95 (9), 1526, 2010 | 213 | 2010 |
| Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 … MA Sanz, P Montesinos, E Vellenga, C Rayón, J De La Serna, R Parody, ... Blood, The Journal of the American Society of Hematology 112 (8), 3130-3134, 2008 | 185 | 2008 |
Myriam LabopinVerified email at ebmt.org
